Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

SH PHARMA

12.580
+0.3803.11%
Volume:10.78M
Turnover:133.89M
Market Cap:46.65B
PE:9.37
High:12.580
Open:12.280
Low:12.220
Close:12.200
Loading ...
OverviewCompanyNewsFilings

Shanghai Pharmaceuticals Gets Nod to Market Pregabalin Capsules in Thailand

MT Newswires Live
·
20 Jun

Shanghai Pharmaceuticals' Unit Gets Registration Certificate for Wenjing Decoction Granules

MT Newswires Live
·
15 May

Shanghai Pharmaceuticals' Unit Gets China Nod to Market Vericiguat

MT Newswires Live
·
13 May

Shanghai Pharmaceuticals Completes Acquisition of SHPL

MT Newswires Live
·
28 Apr

Shanghai Pharmaceuticals' 2024 Profit Jumps 21%, Revenue Up 6%

MT Newswires Live
·
31 Mar

Shanghai Pharmaceuticals Unit Slapped with 165.8 Million Yuan Penalty for Anti-Monopoly Law Breaches

MT Newswires Live
·
24 Mar

Hutchmed Agrees to Dispose 35% of Subsidiary to GP Health Service Capital

MT Newswires Live
·
04 Mar

Shanghai Pharmaceuticals to Invest 1 Billion Yuan in Biomedical M&A Fund

MT Newswires Live
·
29 Jan

Analyst Rate

Buy
Buy
70.00%
Hold
20.00%
Sell
10.00%

Corporate Actions

Ex-dividend Date
Jul 16, 2025 Dividend Per Share 0.316971 HKD
Financial Report Announcement
Apr 28, 2025
Financial Report Announcement
Mar 27, 2025
Financial Report Announcement
Oct 29, 2024
Ex-dividend Date
Sep 17, 2024 Dividend Per Share 0.087355 HKD

Dividend History

Ex-DateDividend
2016-07-150.38866
2017-07-120.412403
2018-07-120.461249
2019-07-120.466781
2020-07-160.481236

Valuation Analysis

14.70
Current
12.25
Sector Average
79.62%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
14.70
Maximum
17.88
+1 STD
14.95
Minimum
7.00
-1 STD
9.56
Average
12.25

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.